Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Change in Account Payables (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Change in Account Payables readings, the most recent being $18.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 1122.78% year-over-year to $18.2 million, compared with a TTM value of $18.2 million through Dec 2025, up 1573.37%, and an annual FY2025 reading of $18.2 million, up 1573.37% over the prior year.
  • Change in Account Payables hit $18.2 million in Q4 2025 for Apellis Pharmaceuticals, up from -$15.6 million in the prior quarter.
  • The five-year high for Change in Account Payables was $23.1 million in Q4 2022, with the low at -$15.6 million in Q3 2025.
  • Median Change in Account Payables over the past 5 years was -$481000.0 (2021), compared with a mean of $2.4 million.
  • The sharpest move saw Change in Account Payables crashed 8567.47% in 2022, then surged 1122.78% in 2025.
  • Year by year, Change in Account Payables stood at $13.7 million in 2021, then skyrocketed by 68.8% to $23.1 million in 2022, then decreased by 15.16% to $19.6 million in 2023, then plummeted by 92.42% to $1.5 million in 2024, then skyrocketed by 1122.78% to $18.2 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $18.2 million, -$15.6 million, and -$1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.